Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1977 1
1978 1
1979 1
1983 1
1984 1
1985 2
1987 1
1991 2
1993 1
1994 4
1997 1
1998 1
2000 3
2001 1
2002 4
2004 1
2005 1
2007 4
2008 4
2009 5
2010 1
2011 3
2012 2
2013 1
2014 9
2015 2
2016 4
2017 9
2018 5
2019 4
2020 6
2021 4
2022 7
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Thyroid Gland Anaplastic Carcinoma"
Page 1
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Haddad RI, Bischoff L, Ball D, Bernet V, Blomain E, Busaidy NL, Campbell M, Dickson P, Duh QY, Ehya H, Goldner WS, Guo T, Haymart M, Holt S, Hunt JP, Iagaru A, Kandeel F, Lamonica DM, Mandel S, Markovina S, McIver B, Raeburn CD, Rezaee R, Ridge JA, Roth MY, Scheri RP, Shah JP, Sipos JA, Sippel R, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Yeh M, Cassara CJ, Darlow S. Haddad RI, et al. J Natl Compr Canc Netw. 2022 Aug;20(8):925-951. doi: 10.6004/jnccn.2022.0040. J Natl Compr Canc Netw. 2022. PMID: 35948029
Anaplastic thyroid carcinoma is almost uniformly lethal, and iodine-131 imaging and radioactive iodine cannot be used. ...This article describes NCCN recommendations regarding management of medullary thyroid carcinoma and anaplastic th …
Anaplastic thyroid carcinoma is almost uniformly lethal, and iodine-131 imaging and radioactive iodine cannot be used. …
Molecular basis and targeted therapy in thyroid cancer: Progress and opportunities.
Zhang L, Feng Q, Wang J, Tan Z, Li Q, Ge M. Zhang L, et al. Biochim Biophys Acta Rev Cancer. 2023 Jul;1878(4):188928. doi: 10.1016/j.bbcan.2023.188928. Epub 2023 May 29. Biochim Biophys Acta Rev Cancer. 2023. PMID: 37257629 Free article. Review.
Thyroid cancer (TC) is the most prevalent endocrine malignant tumor. Surgery, chemotherapy, radiotherapy, and radioactive iodine (RAI) therapy are the standard TC treatment modalities. However, recurrence or tumor metastasis remains the main challenge in the managem …
Thyroid cancer (TC) is the most prevalent endocrine malignant tumor. Surgery, chemotherapy, radiotherapy, and radioactive iodine (RAI …
Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Fallahi P, Ferrari SM, Galdiero MR, Varricchi G, Elia G, Ragusa F, Paparo SR, Benvenga S, Antonelli A. Fallahi P, et al. Semin Cancer Biol. 2022 Feb;79:180-196. doi: 10.1016/j.semcancer.2020.11.013. Epub 2020 Nov 26. Semin Cancer Biol. 2022. PMID: 33249201 Review.
Thyroid cancer (TC) is the eighth most frequently diagnosed cancer worldwide with a rising incidence in the past 20 years. ...Several tyrosine kinase inhibitors (TKIs) are emerging as new treatments for DTC, MTC and anaplastic TC (ATC), and can induce a clinical …
Thyroid cancer (TC) is the eighth most frequently diagnosed cancer worldwide with a rising incidence in the past 20 years. ...Several …
Follicular cell-derived thyroid cancer.
Dralle H, Machens A, Basa J, Fatourechi V, Franceschi S, Hay ID, Nikiforov YE, Pacini F, Pasieka JL, Sherman SI. Dralle H, et al. Nat Rev Dis Primers. 2015 Dec 10;1:15077. doi: 10.1038/nrdp.2015.77. Nat Rev Dis Primers. 2015. PMID: 27188261 Review.
Follicular cell-derived thyroid cancers are derived from the follicular cells in the thyroid gland, which secrete the iodine-containing thyroid hormones. ...In thyroid cancer surgery, for instance, injuries to structures outside the thyroid …
Follicular cell-derived thyroid cancers are derived from the follicular cells in the thyroid gland, which secrete the i …
Anaplastic thyroid carcinoma: pathogenesis and emerging therapies.
Smallridge RC, Copland JA. Smallridge RC, et al. Clin Oncol (R Coll Radiol). 2010 Aug;22(6):486-97. doi: 10.1016/j.clon.2010.03.013. Epub 2010 Apr 24. Clin Oncol (R Coll Radiol). 2010. PMID: 20418080 Free PMC article. Review.
Anaplastic thyroid carcinoma ranges from 1.3 to 9.8% of all thyroid cancers globally. ...The variables associated with survival in some series included age, tumour size, extent of surgery, higher dose radiotherapy, absence of distant metastases at pres …
Anaplastic thyroid carcinoma ranges from 1.3 to 9.8% of all thyroid cancers globally. ...The variables associate …
Anaplastic thyroid carcinoma.
Haigh PI. Haigh PI. Curr Treat Options Oncol. 2000 Oct;1(4):353-7. doi: 10.1007/s11864-000-0051-8. Curr Treat Options Oncol. 2000. PMID: 12057160 Review.
Anaplastic thyroid carcinoma (ATC) is a rare, highly aggressive tumor characterized by rapid growth that causes death soon after diagnosis. ...Surgical extirpation with radical organ resection is associated with high morbidity, and, although an aggressive sur …
Anaplastic thyroid carcinoma (ATC) is a rare, highly aggressive tumor characterized by rapid growth that causes death s …
Genomic and Transcriptomic Correlates of Thyroid Carcinoma Evolution after BRAF Inhibitor Therapy.
Lee M, Untch BR, Xu B, Ghossein R, Han C, Kuo F, Valero C, Nadeem Z, Patel N, Makarov V, Dogan S, Wong RJ, Sherman EJ, Ho AL, Chan TA, Fagin JA, Morris LGT. Lee M, et al. Mol Cancer Res. 2022 Jan;20(1):45-55. doi: 10.1158/1541-7786.MCR-21-0442. Epub 2021 Oct 11. Mol Cancer Res. 2022. PMID: 34635506 Free PMC article.
The molecular alterations associated with thyroid cancer dedifferentiation in the setting of BRAF inhibition are unknown. We analyzed targeted next-generation sequencing data from 639 advanced, recurrent and/or metastatic thyroid carcinomas, including 15 tumo …
The molecular alterations associated with thyroid cancer dedifferentiation in the setting of BRAF inhibition are unknown. We analyzed …
Indications of external beams radiation for thyroid cancer.
Roukoz C, Gregoire V. Roukoz C, et al. Curr Opin Otolaryngol Head Neck Surg. 2022 Apr 1;30(2):137-144. doi: 10.1097/MOO.0000000000000795. Curr Opin Otolaryngol Head Neck Surg. 2022. PMID: 35152242 Review.
RECENT FINDINGS: Based on retrospective studies, adjuvant EBRT lessens the risk of locoregional recurrence in locally advanced differentiated thyroid cancer (DTC) and medullary thyroid cancer (MTC) with high-risk features. ...SUMMARY: The role of EBRT in t …
RECENT FINDINGS: Based on retrospective studies, adjuvant EBRT lessens the risk of locoregional recurrence in locally advanced differ …
A sequential targeting nanoplatform for anaplastic thyroid carcinoma theranostics.
Wang Q, Sui G, Wu X, Teng D, Zhu L, Guan S, Ran H, Wang Z, Wang H. Wang Q, et al. Acta Biomater. 2020 Jan 15;102:367-383. doi: 10.1016/j.actbio.2019.11.043. Epub 2019 Nov 26. Acta Biomater. 2020. PMID: 31778831
In this study, we engineered multifunctional sequential targeting NPs for achieving synergistic antiangiogenic photothermal therapy (PTT) and multimodal imaging-guided diagnosis for anaplastic thyroid carcinoma (ATC) theranostics. Antibody bevacizumab with an …
In this study, we engineered multifunctional sequential targeting NPs for achieving synergistic antiangiogenic photothermal therapy (PTT) an …
Target therapy for BRAF mutated anaplastic thyroid cancer: a clinical and molecular study.
da Silva TN, Rodrigues R, Saramago A, Pires C, Rito M, Horta M, Martins C, Leite V, Cavaco BM. da Silva TN, et al. Eur J Endocrinol. 2023 Jan 10;188(1):lvac011. doi: 10.1093/ejendo/lvac011. Eur J Endocrinol. 2023. PMID: 36651156
OBJECTIVES: Anaplastic thyroid carcinoma (ATC) has a poor survival. The combination of Dabrafenib plus Trametinib (DT) had a significant impact in survival of BRAF p.V600E patients. ...No severe adverse events were reported. Molecular profiling showed that in …
OBJECTIVES: Anaplastic thyroid carcinoma (ATC) has a poor survival. The combination of Dabrafenib plus Trametinib (DT) …
92 results